Molybdenum disulfide thermosensitive hydrogel disrupts biofilms to heal diabetic wounds

Diabetic wounds have long been among the most stubborn challenges in clinical medicine. High blood sugar, poor circulation, and a chronically inflamed microenvironment conspire to stall the normal repair process, turning minor injuries into chronic ulcers that can persist for months or years. To make matters worse, these open lesions frequently become colonized by bacteria that assemble into biofilms—structured, slimy microbial communities that shield pathogens from both antibiotics and the immune system. A research team in China has now engineered a smart, injectable hydrogel that attacks this problem on multiple fronts at once, combining heat-based bacterial killing, nanoparticle-driven antimicrobial action, and fine-tuned regulation of the wound’s chemistry. The work, published in the Journal of Materials Science, demonstrates impressive results both in laboratory assays and in living diabetic mice, suggesting a promising new direction for treating one of diabetes’ most debilitating complications.

The material at the heart of the study is a thermosensitive hydrogel loaded with two types of functional nanomaterials: flower-shaped nanoparticles of molybdenum disulfide (MoS2) and zinc oxide (ZnO) nanoparticles, all embedded within a matrix formed from tannic acid and glycerol monostearate derivatives. The researchers designated this composite MoS2–ZnO@TM/TA. Each component plays a distinct role. The MoS2 nanoflowers are potent photothermal agents: when illuminated with near-infrared (NIR) light, they absorb the radiation and convert it into localized heat with high efficiency. ZnO nanoparticles contribute intrinsic antibacterial activity, partly through the release of zinc ions, which disrupt bacterial membranes and metabolism, and partly through their capacity to modulate reactive oxygen species. Tannic acid, a plant-derived polyphenol, acts as a natural crosslinker and antioxidant, while the lipid-derived monoglyceride component confers the temperature-sensitive gelation behavior that makes the material injectable.

The physical characterization of the hydrogel reveals a suite of properties that are unusually well matched to the demands of wound treatment. At room temperature in phosphate-buffered saline, the material swells to 93 percent of its capacity, allowing it to absorb wound exudate without dissolving. More striking is its shear-thinning rheology: when the shear rate applied to the material increases from 0.1 to 100 per second, its viscosity plummets from 1423 millipascal-seconds down to just 26. In practical terms, this means the hydrogel is thick and stable when sitting still, but flows readily when pushed through a syringe needle. Once deposited into the irregular geometry of a wound bed, it resettles into a soft, conformal gel that maintains intimate contact with the tissue. This injectability is a significant advantage over preformed dressings, which often fail to fill deep or unevenly shaped lesions.

The hydrogel’s responsiveness does not stop at shear. The material also exhibits temperature- and pH-sensitive behavior, which is critical because diabetic wounds present an abnormal microenvironment: they tend to be warmer than healthy skin, more acidic due to accumulated lactic acid and bacterial metabolism, and enriched in degradative enzymes. By tuning the gel matrix so that its structure and release profiles respond to these cues, the researchers built a degree of “intelligence” into the dressing. The hydrogel remains stable under normal conditions but becomes more active precisely where the pathological conditions of a chronic wound exist, delivering its therapeutic payloads where they are needed most and limiting off-target effects on healthy surrounding skin.

The photothermal performance of the composite is central to its antibacterial power. Under near-infrared light at an irradiance of 0.8 watts per square centimeter, the hydrogel raises the local temperature to 53 degrees Celsius within just eight minutes. This level of heating is lethal to bacteria but, when carefully controlled, tolerable for surrounding tissue over short exposures—a therapeutic window that photothermal therapy strategies have exploited in recent years. The heat disrupts bacterial membranes, denatures essential proteins, and, crucially, attacks the extracellular polymeric substance matrix that glues biofilms together. Biofilms are notoriously resistant to conventional antibiotics, with embedded cells often tolerating drug concentrations hundreds to thousands of times higher than their free-swimming counterparts. Physical heat penetrates this protective matrix in a way that molecules often cannot.

The antimicrobial results reported in the study are dramatic. The photothermal hydrogel achieved a 98 percent kill rate against both multidrug-resistant Escherichia coli and multidrug-resistant Staphylococcus aureus, two of the most clinically worrisome wound pathogens. Against established biofilms, the material cleared more than 80 percent of the biomass. These figures matter because multidrug-resistant infections are rising globally, and the World Health Organization has identified antimicrobial resistance as one of the top threats to public health. A dressing that does not rely on antibiotics at all, but instead on physical and nanoscale mechanisms that bacteria have difficulty resisting, offers a valuable alternative in the arms race against resistant organisms.

Mechanistically, the system operates through what the authors describe as a synergistic triad of “photothermal sterilization, inflammatory repair, and microenvironment regulation.” The MoS2 nanoflowers generate the heat that kills bacteria and breaks up biofilms. The ZnO component provides ongoing ion-based antimicrobial pressure between light treatments and contributes zinc ions that support tissue repair processes. The tannic acid within the network scavenges excess reactive oxygen species, which are known to accumulate in chronic wounds and perpetuate tissue damage, while also modulating the inflammatory response that otherwise stalls healing in the chronic phase. Together, these actions shift the wound from a destructive, bacteria-dominated state toward one permissive for cell migration, angiogenesis, and new tissue formation.

The in vivo evidence comes from experiments in diabetic mouse models, which are the standard preclinical platform for wound-healing studies. The results were striking. By day 9 after hydrogel treatment, new skin tissue had already emerged over the treated wounds—a stage at which untreated lesions typically remain open and inflamed. By day 21, the wounds treated with the hydrogel showed a healing rate approximately 50 percent higher than that of the blank control group. Histological assessments accompanying the study indicated improved re-epithelialization and tissue organization in the treated animals. The researchers also reported that the material is biocompatible, an essential prerequisite for any clinical translation, with no significant toxicity observed toward host cells in the tested conditions.

The broader significance of this work lies in how it reframes the problem of diabetic wound care. Traditional dressings are largely passive: they keep the wound moist and provide a physical barrier, but they do little to actively reshape the hostile biology of a chronic lesion. Antibiotic-laden dressings face the twin problems of resistance and off-target disruption of beneficial microbes. The MoS2–ZnO@TM/TA hydrogel represents a third path—an active, multifunctional platform that senses and responds to the wound environment, physically destroys biofilms with light-triggered heat, and simultaneously calms the inflammatory storm that keeps diabetic wounds frozen in a non-healing state. The ability to inject the material also opens the door to minimally invasive application, potentially allowing clinicians to treat deep or tunneling wounds that conventional dressings cannot reach.

Challenges remain before such a system could reach patients. The study relies on near-infrared light delivered from an external source, which raises questions about penetration depth in thick or deeply located tissues, and the long-term fate of the inorganic nanoparticles within the body will require careful toxicological scrutiny. Scaling up the synthesis of well-characterized MoS2 nanoflowers and ensuring batch-to-batch consistency are further hurdles. Nevertheless, the convergence of injectability, on-demand photothermal activation, antibiotic-free bacterial killing, and microenvironment-responsive behavior in a single material marks a substantial advance. For the millions of people worldwide at risk of diabetic foot ulcers—lesions that too often end in amputation—this multifunctional hydrogel offers a glimpse of a future in which wound dressings do far more than cover an injury: they actively fight it.